Targeting human C-type lectin-like molecule-1 (CLL1) with a bispecific antibody for immunotherapy of acute myeloid leukemia
about
At the Interface of Chemical and Biological Synthesis: An Expanded Genetic Code.Targeting CD157 in AML using a novel, Fc-engineered antibody construct.A novel, native-format bispecific antibody triggering T-cell killing of B-cells is robustly active in mouse tumor models and cynomolgus monkeys.Update on antigen-specific immunotherapy of acute myeloid leukemia.Antigen-specific immunotherapy for acute myeloid leukemia: where are we now, and where do we go from here?Antibody-Based Treatment of Acute Myeloid Leukemia.Acute myeloid leukemia targets for bispecific antibodies.Treatment of Acute Myeloid Leukemia with T Cells Expressing Chimeric Antigen Receptors Directed to C-type Lectin-like Molecule 1.Unravelling the relevance of CLEC12A as a cancer stem cell marker in myelodysplastic syndrome.Development of A Chimeric Antigen Receptor Targeting C-Type Lectin-Like Molecule-1 for Human Acute Myeloid Leukemia.Mapping the CLEC12A expression on myeloid progenitors in normal bone marrow; implications for understanding CLEC12A-related cancer stem cell biology.Redirecting T cells to hematological malignancies with bispecific antibodies.CAR-T cells targeting CLL-1 as an approach to treat acute myeloid leukemia.Novel strategies for targeting leukemia stem cells: sounding the death knell for blood cancer.Low CLL-1 Expression Is a Novel Adverse Predictor in 123 Patients with De Novo CD34+ Acute Myeloid Leukemia.Site-Specific Antibody Conjugation for ADC and Beyond.Phenotypic characterization of aberrant stem and progenitor cell populations in myelodysplastic syndromes.Therapeutic applications of genetic code expansion
P2860
Q30390524-A041E136-D2C4-4661-A355-0979254E8927Q33829283-9D8C53E9-ED76-460F-87F7-68AED13B1339Q36363779-4BE4C0BB-CDCE-4466-A4B0-BB6D9B41B411Q38432103-1F75659B-BEEE-425C-91A9-91458BE833ADQ38700209-B6D1FA0E-EF5A-4732-8849-7E1E0DB8ABFBQ38979277-D0458ABA-14F9-47DE-B719-D361DED11784Q39117761-1053A892-1FC6-407C-9EBC-203698708E6BQ40135347-9E8741C4-42D0-41B6-B56F-8790A14A6961Q40483682-BA68625A-672D-420A-8C8F-6261292B2B08Q47139132-3AF5A1DF-389E-4700-B32E-DABA200202DFQ48091597-1B0DE8C5-450D-4634-8ED7-498F141AC07BQ48339827-DBF075E9-39A2-4684-9B09-42645FFD1DD4Q49168672-9EDC4C84-4B42-4DD0-8D51-F9EE9095CEBFQ52846906-772B00B7-7142-4D6F-BCE8-DFA6581BE695Q53110546-7756D6D8-1497-437E-961D-7BAF361A9F67Q55022669-A07163FB-A702-4259-9ABC-75BF19B5BC35Q55360759-1FB49CEC-3F02-4751-BC1A-A450C0C8B17DQ57818219-9D7D588E-7E63-4C7C-ADDF-CDCCCEDE7FC8
P2860
Targeting human C-type lectin-like molecule-1 (CLL1) with a bispecific antibody for immunotherapy of acute myeloid leukemia
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Targeting human C-type lectin- ...... rapy of acute myeloid leukemia
@en
type
label
Targeting human C-type lectin- ...... rapy of acute myeloid leukemia
@en
prefLabel
Targeting human C-type lectin- ...... rapy of acute myeloid leukemia
@en
P2093
P2860
P356
P1476
Targeting human C-type lectin- ...... rapy of acute myeloid leukemia
@en
P2093
Brian R Lawson
Chan Hyuk Kim
Claire Bouvard
Hardeep Phull
Jennifer Ma
Peter G Schultz
Rahul R Naik
Seihyun Choi
Shoutian Zhu
P2860
P304
P356
10.1002/ANIE.201405353
P407
P577
2014-07-23T00:00:00Z